A review of sarilumab for the treatment of rheumatoid arthritis.
Sign Up to like & getrecommendations! Published in 2018 at "Immunotherapy"
DOI: 10.2217/imt-2017-0075
Abstract: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease predominantly affecting the peripheral diarthrodial joints. Sarilumab is a human monoclonal antibody against the IL-6 receptor-α. In Phase II and III clinical trials, sarilumab in the… read more here.
Keywords: sarilumab treatment; review sarilumab; rheumatoid arthritis; inadequate response ... See more keywords